Welcome to our dedicated page for 111 SEC filings (Ticker: YI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
111, Inc. filings document foreign-issuer current reports furnished on Form 6-K, primarily covering unaudited quarterly and annual financial results for its China healthcare platform. The disclosures report net revenues, gross segment profit, operating expenses, operating cash flow and segment activity tied to the company’s B2B and B2C healthcare businesses.
The filing record also describes the company’s transition toward an asset-light warehouse partnership model, including subsidiary divestitures that shifted certain fulfillment facilities into partner roles. These reports provide formal disclosure of business performance, margin trends, liquidity measures, ADR reporting status and material operating updates furnished to U.S. markets.
111, Inc. board member Gang Yu filed an initial Form 3 detailing his existing equity interests in the company. As of this filing, he holds 36,000,000 Class B shares, 176,000 Class A ADSs, and 292,362 vested RSUs tied to Class A ordinary shares. He also has 750 additional Class A RSUs outstanding, each representing a right to receive one share at no cash cost before they expire on 2029-12-31.
111, Inc., a China-based company listed in the U.S., submitted a foreign issuer report for September 2025. The report mainly serves to provide an exhibit in which the company announces its unaudited financial results for the second quarter of 2025. The document is signed on behalf of the company by Chief Executive Officer Junling Liu.
111, Inc. (YI) disclosures show a company managing liquidity through multiple bank credit facilities and operational measures while reporting improving cash generation. The Group had positive operating cash flows of RMB 263,016 for the year ended December 31, 2024 and maintained a Master Guarantee Facility with RMB 100,000 committed (RMB 50,000 undrawn at issuance). Additional facilities include a credit line up to RMB 30,000 expiring January 2026 and other working-capital arrangements drawn and repaid during 2023–2024.
Other disclosures note segment reporting for B2C and B2B, treatment of marketplace revenue as principal/agent, reverse factoring outstanding RMB nil in 2024 (was RMB 98,109 in 2023), share-based plans and repurchases at subsidiary level, and restricted PRC subsidiary capital of RMB 618,830 and RMB 639,000 not available for distribution.
111, Inc. (YI) disclosures show a company managing liquidity through multiple bank credit facilities and operational measures while reporting improving cash generation. The Group had positive operating cash flows of RMB 263,016 for the year ended December 31, 2024 and maintained a Master Guarantee Facility with RMB 100,000 committed (RMB 50,000 undrawn at issuance). Additional facilities include a credit line up to RMB 30,000 expiring January 2026 and other working-capital arrangements drawn and repaid during 2023–2024.
Other disclosures note segment reporting for B2C and B2B, treatment of marketplace revenue as principal/agent, reverse factoring outstanding RMB nil in 2024 (was RMB 98,109 in 2023), share-based plans and repurchases at subsidiary level, and restricted PRC subsidiary capital of RMB 618,830 and RMB 639,000 not available for distribution.